CCDC107, or Coiled-Coil Domain Containing 107, is a protein-coding gene that exists in various organisms, including humans, rats, and mice . It is implicated in diseases such as anauxetic dysplasia 1 and cartilage-hair hypoplasia . Research indicates that the expression of CCDC107 can be influenced by various chemical compounds . Due to the limited research on CCDC107, it is considered a poorly understood target with no known drug or small molecule activities .
CCDC107 expression is affected by several compounds. The following table summarizes the interactions of CCDC107 with different chemicals in rats :
| Chemical Compound | Effect on Expression |
|---|---|
| (+)-catechin | Decreased |
| (1->4)-beta-D-glucan | Increased |
| 1,2-dimethylhydrazine | Increased |
| 1,3-dinitrobenzene | Increased |
| 2,3,7,8-tetrachlorodibenzodioxine | Varies |
| 2,3,7,8-tetrachlorodibenzofuran | Increased |
| 2-hydroxypropanoic acid | Decreased |
| 3-isobutyl-1-methyl-7H-xanthine | Increased |
| 4,4'-sulfonyldiphenol | Increased |
| Cisplatin | Decreased |
| Clofibrate | Increased |
| Copper(II) sulfate | Affected |
| Dexamethasone | Increased |
| Inulin | Increased |
| L-methionine | Increased |
| Nefazodone | Decreased |
| Nimesulide | Decreased |
| Nitrates | Increased |
| Paracetamol | Affected |
| Perfluorononanoic acid | Decreased |
| Perfluorooctane-1-sulfonic acid | Increased |
Recombinant CCDC107 protein is produced using genetic engineering techniques, often expressed in E. coli . For example, Creative BioMart offers a recombinant full-length bovine CCDC107 protein with a His-tag, expressed in E. coli . This recombinant protein can be used in various research applications.
The recombinant form of proteins like CCDC107 is often expressed in E. coli to facilitate research . After expression, the protein is purified for use in experiments. For instance, the recombinant CRM197 protein, structurally and immunologically similar to its C7 counterpart, can be used as a carrier protein in conjugate vaccine development .
Functional characterization is essential to understand the role of CCDC107. Studies involving protein variants, such as those observed in protein C, help elucidate the functional significance of specific residues . These studies often involve in vitro and cellular assays to assess anticoagulant and anti-inflammatory properties .
ELISA (Enzyme-Linked Immunosorbent Assay) kits are available for quantifying CCDC107 in bovine samples . These kits are designed for research purposes to measure the levels of CCDC107 in biological samples .
The study of recombinant proteins like CCDC107 is significant in vaccine development . Recombinant proteins can serve as carrier proteins in conjugate vaccines, enhancing the immunogenicity of polysaccharides .
KEGG: bta:514786
UniGene: Bt.53868
Optimal storage of recombinant CCDC107 requires maintaining protein stability while preventing degradation. Storage recommendations include:
Primary storage at -20°C in a Tris-based buffer with 50% glycerol
For extended preservation, use -80°C storage
Avoid repeated freeze-thaw cycles as they significantly compromise protein structure
For ongoing experiments, working aliquots can be maintained at 4°C for up to one week
Consider adding protease inhibitors if degradation is observed during functional assays
These conditions are optimized for this specific protein, as coiled-coil domains can be particularly susceptible to aggregation when improperly stored.
| Expression System | Advantages | Limitations | Best For |
|---|---|---|---|
| E. coli | High yield, cost-effective | May lack PTMs, potential inclusion bodies | Structure studies, antibody production |
| Mammalian cells | Native folding, PTMs preserved | Lower yield, higher cost | Functional assays, protein-protein interactions |
| Insect cells | Good compromise of yield and PTMs | Medium complexity, time-consuming | Complex domain proteins requiring PTMs |
When expressing CCDC107, induction conditions of 0.5-1mM IPTG at 18-20°C overnight often reduces inclusion body formation common with coiled-coil domain proteins. A dual-tag approach (His-tag combined with another solubility tag like MBP) can improve both purification efficiency and protein solubility .
A multi-step purification protocol is recommended:
Initial capture using affinity chromatography (Ni-NTA for His-tagged protein)
Intermediate purification via ion exchange chromatography
Polishing step using size exclusion chromatography
For optimal results, maintain buffering conditions at pH 7.5-8.0 and include 150-300mM NaCl to prevent protein aggregation. The addition of reducing agents (1-5mM DTT or 0.5-2mM TCEP) helps maintain disulfide bonds in their proper state. Researchers should verify final protein quality through SDS-PAGE, Western blotting, and mass spectrometry prior to functional assays .
To elucidate the subcellular distribution of CCDC107:
Immunofluorescence microscopy: Transfect bovine cell lines with CCDC107-GFP fusion constructs and co-stain with markers for cellular compartments (ER, Golgi, mitochondria)
Subcellular fractionation: Separate cellular components via ultracentrifugation and detect CCDC107 in different fractions using Western blotting
Live cell imaging: For dynamic trafficking studies, use photoactivatable fluorescent tags to track protein movement in real-time
Based on similar coiled-coil domain proteins studied in bovine tissues, CCDC107 may associate with cytoskeletal elements or function in membrane organization. Quantitative co-localization analysis with structural markers can reveal functional associations not apparent from sequence data alone .
Several complementary approaches should be employed:
Co-immunoprecipitation (Co-IP): Pull down CCDC107 from bovine cell lysates and identify binding partners via mass spectrometry
Yeast two-hybrid screening: Identify novel interacting proteins using CCDC107 as bait
Proximity labeling techniques: BioID or APEX2 fusion proteins can identify proximal interactors in living cells
Surface plasmon resonance (SPR): Determine binding kinetics and affinity for identified interactions
When designing these experiments, consider that coiled-coil domains typically mediate specific protein-protein interactions, often forming homo- or hetero-oligomeric complexes. Controls should include truncated versions lacking the coiled-coil domains to verify domain-specific interactions .
While specific CCDC107 expression data is limited, research approaches should include:
Tissue microarrays: Quantitative immunohistochemistry across multiple bovine tissues
qRT-PCR analysis: Expression profiling in various tissues and developmental timepoints, using primers:
Forward: 5'-TCTGAAGCTGAGCTCCAA-3'
Reverse: 5'-AAATTGGTCAAACGGATCCA-3'
Single-cell RNA sequencing: To identify cell type-specific expression patterns
Similar to other coiled-coil domain proteins in bovine models, CCDC107 may show tissue-specific expression patterns correlated with specialized cellular structures or functions. Researchers should normalize expression data to multiple reference genes such as GAPDH and β-actin to ensure accurate quantification .
To investigate transcriptional and post-transcriptional regulation:
Promoter analysis: Bioinformatic identification of transcription factor binding sites and experimental validation via reporter assays
Epigenetic regulation: Assess methylation status of the CCDC107 promoter region and histone modifications via ChIP-seq
miRNA targeting: Identify potential miRNA binding sites in the 3'UTR and validate using luciferase reporter assays
Post-translational modifications: Phosphorylation, acetylation, or ubiquitination sites that may influence protein stability or function
Studies of related proteins suggest potential regulation via cell cycle-dependent kinases or tissue-specific transcription factors, which should be experimentally validated for CCDC107 .
Effective gene editing strategies for CCDC107 require:
gRNA design: Multiple gRNAs targeting exons 1-3 of the CCDC107 gene, predicted using algorithms that minimize off-target effects
Verification methods:
Genomic PCR and sequencing to confirm edits
Western blotting to verify protein depletion
RT-qPCR to assess mRNA levels
Functional rescue experiments: Re-expression of wild-type CCDC107 to confirm phenotype specificity
For temporal control, inducible knockdown systems may better reveal acute versus chronic effects of CCDC107 depletion. Based on studies of related proteins, CCDC107 knockout might affect cellular processes like proliferation or differentiation, which should be assessed using appropriate assays .
When investigating CCDC107's involvement in differentiation processes:
Cell model selection: Consider using bovine intramuscular preadipocytes (BIMP) or bovine satellite cells that undergo well-characterized differentiation
Temporal analysis: Track CCDC107 expression through a differentiation time course using both mRNA and protein quantification
Gain/loss-of-function effects: Overexpress or knockdown CCDC107 at specific differentiation stages to determine temporal requirements
Downstream marker analysis: Quantify expression of differentiation markers such as PPARγ, C/EBPα, and tissue-specific transcription factors following CCDC107 manipulation
Research on related proteins suggests monitoring cell cycle regulators (Cyclin D1, Cyclin B1) alongside differentiation markers, as many coiled-coil domain proteins have dual roles in proliferation and differentiation. Oil Red O staining can assess adipogenic differentiation potential, while myogenic markers like MyoD and myogenin should be monitored for muscle differentiation .
CCDC107's coiled-coil domains can present challenges for protein stability. Implement these solutions:
Buffer optimization: Screen multiple buffer conditions varying:
pH (6.5-8.5)
Salt concentration (100-500mM NaCl)
Additives (5-10% glycerol, 0.1-0.5% non-ionic detergents)
Fusion partners: Consider solubility-enhancing tags such as MBP, SUMO, or Thioredoxin
Expression temperature: Reduce to 16-18°C to slow folding and improve proper domain organization
Protein quality assessment: Dynamic light scattering (DLS) can detect early aggregation before it becomes visible
Storage recommendations: Maintain in Tris-based buffer with 50% glycerol at -20°C or -80°C for extended storage
A systematic approach to troubleshooting using design of experiments (DOE) methodology can efficiently identify optimal conditions for maintaining CCDC107 stability.
Researchers frequently encounter these challenges when studying CCDC107 interactions:
Non-specific binding: Use stringent controls including:
Unrelated proteins with similar biochemical properties
Versions of CCDC107 with mutated interaction domains
Competitive binding assays with synthetic peptides
Buffer incompatibility: Interaction buffers may differ from optimal storage conditions; perform buffer screening to find conditions supporting both protein stability and physiologically relevant interactions
Transient interactions: Consider crosslinking approaches or proximity labeling for weakly interacting partners
Binding environment specificity: Some interactions may require specific cellular contexts (membrane association, pH, or lipid composition)
For proteins like CCDC107 with coiled-coil domains, interactions can be highly conformation-dependent. Always validate in vitro interactions with cellular assays such as FRET, BiFC, or co-localization studies .
Comparative analysis provides insight into conserved functions:
| Species | Sequence Identity | Key Structural Differences | Functional Implications |
|---|---|---|---|
| Human | ~85-90% (predicted) | Minor variations in C-terminal region | Likely conserved core function |
| Mouse | ~80-85% (predicted) | Variations in coiled-coil spacing | Potential species-specific interactions |
| Rat | ~80% (predicted) | Similar to mouse variations | Similar to mouse implications |
| Zebrafish | ~60% (predicted) | More divergent C-terminus | Possible developmental role differences |
Phylogenetic analysis suggests CCDC107 evolved under purifying selection, indicating functional importance. The highest conservation typically occurs in the coiled-coil domains, supporting their functional significance. Cross-species functional complementation experiments can test functional conservation hypotheses .
Multiple computational strategies should be employed:
Protein domain prediction: Tools like SMART, Pfam, and COILS for coiled-coil domain identification and characterization
Structural modeling: AlphaFold2 or I-TASSER for tertiary structure prediction, especially focused on coiled-coil domain arrangements
Protein-protein interaction prediction: Resources such as STRING or BioGRID to identify potential interactors based on co-expression or structural similarity
Subcellular localization prediction: Tools like DeepLoc or PSORT to predict cellular compartmentalization
Post-translational modification sites: NetPhos, UbPred, or other PTM prediction algorithms to identify regulatory sites
Integrating these predictions with experimental validation has proven effective for characterizing novel coiled-coil domain proteins in other systems .
Several research avenues warrant investigation:
Embryonic development: Examining CCDC107 expression and function during early bovine embryogenesis using in vitro fertilized embryos
Tissue differentiation: Investigating potential roles in muscle, adipose, or other tissue development, particularly in economically important traits like marbling in beef cattle
Cell division regulation: Exploring potential functions in cytoskeletal organization during mitosis, similar to other coiled-coil domain proteins
Transgenic models: Developing CCDC107 knockout or reporter cattle to track expression and function in vivo
Research on related proteins suggests CCDC107 may influence cellular processes like proliferation and differentiation, which are critical for tissue development. Studies focusing on cell type-specific expression patterns during different developmental stages could reveal novel functions .
Building on research with related proteins:
Adipogenic differentiation: Given findings with CDC10/Septin 7, investigate CCDC107's potential role in bovine adipogenesis, particularly in intramuscular fat development
Signaling pathway integration: Examine interactions with known differentiation regulators such as PPARγ and C/EBPα pathways
Cell cycle exit coordination: Study potential roles in the transition from proliferation to differentiation phases
Cytoskeletal reorganization: Investigate functions in the structural changes accompanying cellular differentiation
Methodological approaches should include:
Temporal expression profiling during differentiation
Gain and loss-of-function studies at specific differentiation stages
Identification of binding partners specific to differentiating cells
Assessment of effects on lineage-specific transcription factors
Research on CDC10/Septin 7 has shown that similar proteins can promote adipocyte differentiation through mechanisms affecting expression of adipogenic marker genes, suggesting CCDC107 may have comparable functions .